Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upD. Hoelzer, Christian Buske, Renato Bassan et al.|Annals of Oncology|2016Cited by 457
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008Monika Brüggemann, Yves Benoît, Andrea Biondi et al.|Leukemia|2009Cited by 338
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALLPhilippe Rousselot, Oliver G. Ottmann, marie Magdelaine Coude et al.|Blood|2016Cited by 329
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, H Kantarjian, Michael A. Kelsh et al.|Blood Cancer Journal|2016Cited by 128
Management of ALL in adults: 2024 ELN recommendations from a European expert panelNicola Gökbuget, Renato Bassan, Nicolas Boissel et al.|Blood|2024Cited by 120